Previous close | 9.46 |
Open | 9.49 |
Bid | 9.04 x 400 |
Ask | 9.41 x 200 |
Day's range | 9.14 - 9.62 |
52-week range | 8.82 - 21.00 |
Volume | |
Avg. volume | 573,675 |
Market cap | 1.478B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.63 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 25.25 |
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Regeneron (REGN) and Sage Therapeutics (SAGE) are in focus on regulatory and pipeline updates.
The FDA places a clinical hold on Neumora's (NMRA) phase I study evaluating NMRA-266 for some types of neuropsychiatric disorders. Shares of the company fall on the news.